Question 1

What is the catalog number for NVP-ADW742?

Accepted Answer

The catalog number for NVP-ADW742 is M14584.

Question 2

What sizes are available for NVP-ADW742?

Accepted Answer

NVP-ADW742 is available in the following size(s): 1 g, 100 mg, 200 mg, 500 mg, Inquire.

Question 3

How many pack sizes does NVP-ADW742 come in?

Accepted Answer

NVP-ADW742 is available in 5 different pack sizes.

Question 4

Is NVP-ADW742 in stock?

Accepted Answer

NVP-ADW742 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is NVP-ADW742 used for?

Accepted Answer

NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 8

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

NVP-ADW742

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

DNMT1 Antibody: RPE

Human AGBL5 activation kit by CRISPRa

Mini Sample Mouse VCAM-1/CD106 (Vascular cell adhesion molecule 1) ELISA Kit

Mini Sample Mouse VCAM-1/CD106 (Vascular cell adhesion molecule 1) ELISA Kit

Mini Sample Mouse VCAM-1/CD106 (Vascular cell adhesion molecule 1) ELISA Kit

DC SIGN (CD209) Human Gene Knockout Kit (CRISPR)